Astrazeneca (AZN) Payables (2009 - 2026)
Astrazeneca (AZN) recorded Payables of -$25.19 billion in Q3 2026, compared with -$26.12 billion a year earlier.
Powered by 
Analysis
Astrazeneca (AZN) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Astrazeneca reported Payables of $25.27 billion, up 12.8% from FY2024.
- Annual Payables has increased for nine straight years, with a five-year compound annual growth rate of 10.3% (FY2020 to FY2025).
- Across earlier years, Payables came in at $22.41 billion in FY2024 (+1.1%), $22.17 billion in FY2023 (+17.6%), $18.86 billion in FY2022 (+1.6%) and $18.55 billion in FY2021 (+19.7%).
- Quarterly Payables has ranged from -$26.12 billion in Q3 2025 to $25.27 billion in Q4 2025 over the past five years.
- On a year-over-year basis, Payables rose in three of the last four quarters, with growth averaging 6.6%.
- Peak year-over-year performance for Payables in the last five years was growth of 19.7% in Q4 2021, against a decline of 4.6% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $22.89 billion (Q2 2026), -$24.92 billion (Q1 2026) and $25.27 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 472.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -25.19 Bn |
| Jun 30, 2026 | 22.89 Bn |
| Mar 31, 2026 | -24.92 Bn |
| Dec 31, 2025 | 25.27 Bn |
| Sep 30, 2025 | -26.12 Bn |
| Jun 30, 2025 | 23.99 Bn |
| Mar 31, 2025 | -23.49 Bn |
| Dec 31, 2024 | 22.41 Bn |
| Sep 30, 2024 | -22.16 Bn |
| Jun 30, 2024 | 20.46 Bn |
| Mar 31, 2024 | -20.68 Bn |
| Dec 31, 2023 | 22.17 Bn |
| Sep 30, 2023 | -20.79 Bn |
| Jun 30, 2023 | 19.74 Bn |
| Mar 31, 2023 | -19.28 Bn |
| Dec 31, 2022 | 18.86 Bn |
| Sep 30, 2022 | -18.44 Bn |
| Jun 30, 2022 | 17.82 Bn |
| Mar 31, 2022 | -18.12 Bn |
| Dec 31, 2021 | 18.55 Bn |
API Access
Astrazeneca Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();